Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.1400
0.00 (0.00%)
Jan 30, 2026, 10:03 AM AEST
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 7.48 million as of January 30, 2026. Its market cap has decreased by -70.08% in one year.
Market Cap
7.48M
Enterprise Value
7.43M
Revenue
478.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 7.48M, a decrease of -79.35%. That is a compound annual growth rate of -14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 7.48M | -22.22% |
| Dec 31, 2025 | 9.62M | 134.56% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 12.69M |
| AdAlta | 11.48M |
| Chimeric Therapeutics | 11.05M |
| Patrys | 10.22M |
| Biotron | 9.64M |
| Bio-Gene Technology | 9.15M |
| Invex Therapeutics | 9.02M |
| Zelira Therapeutics | 8.09M |